Sintx Technologies (SINT) Enterprise Value Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Sintx Technologies | 8.71 Mn | 6.82 Mn | 144,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 39.59% |
| Dec 31, 2025 | 30.40% |
| Sep 30, 2025 | 25.40% |
| Jun 30, 2025 | 24.93% |
| Mar 31, 2025 | 4.60% |
| Dec 31, 2024 | -15.02% |
| Sep 30, 2024 | -10.47% |
| Jun 30, 2024 | -7.38% |
| Mar 31, 2024 | -6.71% |
| Dec 31, 2023 | 9.32% |
| Sep 30, 2023 | 1.75% |
| Jun 30, 2023 | -1.09% |
| Mar 31, 2023 | -98.57% |
| Dec 31, 2022 | -63.23% |
| Sep 30, 2022 | -11.16% |
| Jun 30, 2022 | -17.49% |
| Mar 31, 2022 | -9.36% |
| Dec 31, 2021 | -15.60% |
| Sep 30, 2021 | -10.12% |
| Jun 30, 2021 | -33.88% |
| Mar 31, 2021 | -24.20% |
| Dec 31, 2020 | -17.16% |
| Sep 30, 2020 | -19.14% |
| Jun 30, 2020 | -7.90% |
| Mar 31, 2020 | 11.19% |
| Dec 31, 2019 | 37.17% |
| Sep 30, 2019 | 22.34% |
| Jun 30, 2019 | 22.68% |
| Mar 31, 2019 | 20.67% |
| Dec 31, 2018 | -19.04% |
| Sep 30, 2018 | 2.12% |
| Jun 30, 2018 | -50.72% |
| Mar 31, 2018 | 28.24% |